Abstracts tagged "Early Rheumatoid Arthritis and polyunsaturated fatty acid"

Abstract Number: 467 • 2019 ACR/ARP Annual Meeting
Serum Long-chain n-3 and -6 Fatty Acids Are Associated with Disease Feature at Onset and with 6-month Disease Activity in Early RA: Results from the ESPOIR Cohort
Johanna Sigaux ¹, Camille Buscail ², Chantal Julia ³, René-Marc Flipo ⁴, Alain Cantagrel ⁵, Bernard Bannwarth ⁶, Francois Laporte ⁷, Salima Challal ⁸, Marie-Christophe Boissier ⁹ and Luca Semerano¹⁰, ¹INSERM UMR 1125, Université Paris 13, Bobigny, France, ²Equipe de Recherche en Epidémiologie Nutritionnelle (EREN) UMR U1153 Inserm/U1125 Inra/Cnam/Univ Paris 13 Centre de Recherche en Epidémiologie et Biostatistiques UFR SMBH, Bobigny, France, ³uipe de Recherche en Epidémiologie Nutritionnelle (EREN) UMR U1153 Inserm/U1125 Inra/Cnam/Univ Paris 13 Centre de Recherche en Epidémiologie et Biostatistiques UFR SMBH, Bobigny, France, ⁴Roger Salengro University-Hospital, Lille , France, Lille, France, ⁵Centre de Rhumatologie, CHU de Toulouse, 31059, Toulouse, France, Toulouse, France, ⁶Service de rhumatologie, hôpital Pellegrin, centre hospitalier universitaire de Bordeaux, Bordeaux, France, ⁷Département de Biochimie- Pharmacologie-Toxicologie CHU de Grenoble, Grenoble, France, ⁸Assistance Publique-Hôpitaux de Paris, Hôpital Avicenne Service de Rhumatologie, Bobigny, France, ⁹Assistance Publique-Hôpitaux de Paris (AP-HP), Rheumatology Department, Avicenne Hospital, Bobigny, France, ¹⁰INSERM UMR 1125 , Université Paris 13, Bobigny, France
Background/Purpose: Long-chain polyunsaturated fatty acids (PUFAs) of the n3 and n6 families can contribute to modulate inflammatory processes. Dietary intake of n3PUFA is inversely associated…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].